Top 10 Centrifuge In China Manufacturers (2026 Audit Report)

H2: 2026 Market Trends for Centrifuges in China

The centrifuge market in China is poised for significant evolution by 2026, driven by advancements in biotechnology, pharmaceuticals, healthcare modernization, and industrial automation. As one of the fastest-growing segments in laboratory and industrial equipment, centrifuges are becoming increasingly critical across multiple sectors. Below is an analysis of key market trends expected to shape the centrifuge industry in China through 2026.

---

1. Surge in Biopharmaceutical and Biotech R&D Investment
China’s government continues to prioritize the development of its biopharmaceutical and life sciences industries through initiatives like “Made in China 2025” and the 14th Five-Year Plan. Increased funding for research in gene therapy, mRNA vaccines, and cell-based treatments is amplifying demand for high-speed, ultracentrifuges and specialized benchtop models. By 2026, domestic biotech firms and contract research organizations (CROs) are expected to account for over 40% of centrifuge procurement, particularly for advanced models capable of handling sensitive biological samples.

---

2. Expansion of Hospital and Diagnostic Infrastructure
China’s healthcare reform agenda emphasizes decentralized medical services and enhanced rural healthcare access. As central and local governments invest in upgrading hospital labs and establishing regional diagnostic centers, demand for clinical centrifuges—especially compact, easy-to-use models for blood and urine analysis—is rising. The trend is further accelerated by aging demographics and increasing prevalence of chronic diseases. By 2026, clinical centrifuges are projected to represent nearly 35% of the total market volume.

---

3. Growth of Domestic Manufacturing and Technological Innovation
While foreign brands (e.g., Thermo Fisher, Eppendorf) still dominate the high-end segment, Chinese manufacturers such as Xiangzhong, Hunan Xiangyi, and ShangHai Centrifuge Institute are rapidly closing the technology gap. Supported by government R&D subsidies and localization policies, domestic firms are launching smart centrifuges with IoT integration, remote monitoring, and AI-assisted maintenance. By 2026, local brands are expected to capture over 50% of the mid-tier market, offering cost-effective, high-performance alternatives.

---

4. Emphasis on Automation and Smart Laboratory Integration
Laboratory automation is gaining momentum in China, especially in large pharmaceutical and academic institutions. Centrifuges are increasingly being integrated into automated workflows, requiring compatibility with robotic sample handlers and LIMS (Laboratory Information Management Systems). The demand for centrifuges with barcode readers, touch-screen interfaces, and cloud connectivity is growing. By 2026, smart centrifuges are anticipated to grow at a CAGR of over 12%, outpacing the overall market.

---

5. Regulatory Support and Standardization
China’s National Medical Products Administration (NMPA) and CNAS (China National Accreditation Service) are tightening standards for medical and laboratory equipment. This regulatory push is encouraging users to replace outdated centrifuges with models compliant with ISO 13485 and other international standards. Additionally, environmental and safety regulations are promoting energy-efficient and low-noise designs, influencing product development strategies.

---

6. Rising Demand in Industrial and Environmental Applications
Beyond life sciences, centrifuges are seeing increased adoption in wastewater treatment, food and beverage processing, and chemical manufacturing. In response to stricter environmental regulations, industrial facilities are investing in decanter and disc-stack centrifuges for sludge dewatering and resource recovery. The industrial segment is expected to grow steadily, contributing approximately 20% of the market value by 2026.

---

7. Supply Chain Localization and Resilience
Geopolitical tensions and pandemic-related disruptions have prompted Chinese buyers to prioritize supply chain security. This has led to a strategic shift toward sourcing centrifuge components—such as rotors, motors, and control systems—domestically. By 2026, over 60% of centrifuge assembly in China is expected to rely on localized supply chains, reducing import dependency and improving delivery timelines.

---

Conclusion
By 2026, China’s centrifuge market will be characterized by technological sophistication, increased localization, and diversification across healthcare, industrial, and research applications. With strong policy support, growing R&D activity, and the rise of smart laboratories, the market is projected to exceed USD 450 million, growing at a CAGR of approximately 8.5% from 2023 to 2026. Companies that invest in innovation, regulatory compliance, and tailored solutions for Chinese end-users will be best positioned to capture market share.

Common Pitfalls Sourcing Centrifuges from China (Quality, IP)

Sourcing centrifuges from China can offer significant cost advantages, but it also comes with notable risks, particularly concerning quality control and intellectual property (IP) protection. Being aware of these pitfalls is crucial for making informed procurement decisions.

Quality-Related Pitfalls

Misrepresented Specifications and Performance Claims
Many Chinese suppliers may exaggerate centrifuge capabilities, such as maximum speed (RPM), relative centrifugal force (RCF), temperature control accuracy, or rotor compatibility. Buyers may receive units that fail to meet published performance benchmarks, leading to unreliable results in sensitive applications.

Inconsistent Manufacturing Standards
While some manufacturers adhere to international standards (e.g., ISO 13485 for medical devices), others prioritize cost-cutting over consistency. This can result in batch-to-batch variability, substandard materials (e.g., inferior rotor alloys), or poor assembly practices that compromise safety and longevity.

Lack of Certification or Fake Certifications
Some suppliers provide counterfeit or unverifiable certifications (e.g., CE, FDA, ISO). Genuine compliance ensures safety and regulatory acceptance, especially in pharmaceutical or clinical labs. Always verify certifications through official databases or third-party audits.

Inadequate After-Sales Support and Spare Parts Availability
Remote troubleshooting, maintenance, and spare parts supply chains can be unreliable. Delays in obtaining critical components like rotors or drive motors can lead to extended equipment downtime, impacting operations.

Intellectual Property (IP) Risks

Unauthorized Replication of Design or Technology
When working with OEM/ODM suppliers, there’s a risk they may reverse-engineer your proprietary design or technology and sell it to competitors. This is especially dangerous if design files or technical specifications are shared without legal safeguards.

Weak IP Enforcement in Cross-Border Disputes
Enforcing IP rights in China can be complex and time-consuming. Even with non-disclosure agreements (NDAs), legal recourse may be limited or ineffective, particularly if the supplier operates through shell companies or changes names.

Co-Mingling of IP in Custom Development
In custom centrifuge projects, unclear contracts may result in disputes over IP ownership. Suppliers might claim joint ownership or reuse design elements in other products, undermining your competitive advantage.

Mitigation Strategies

To reduce these risks, conduct thorough due diligence: perform factory audits, request independent testing reports, verify certifications, and use legally binding agreements that clearly define IP ownership and confidentiality. Partnering with reputable sourcing agents or legal advisors experienced in Chinese manufacturing can further enhance protection.

Logistics & Compliance Guide for Centrifuge in China

Regulatory Classification and Import Licensing

Centrifuges used in laboratories, medical, or industrial settings are typically classified under specific categories by China’s General Administration of Customs (GAC) and the National Medical Products Administration (NMPA). Determine the exact HS Code (e.g., 8470, 8421, or 9027 depending on function) to establish regulatory pathways. Non-medical centrifuges may require only standard import procedures, while medical-use centrifuges are classified as medical devices and may need NMPA registration, particularly if intended for clinical diagnostics. Verify if the centrifuge falls under Category II or III medical devices, which require a China agent and extensive documentation.

Product Certification and Standards Compliance

Ensure the centrifuge complies with Chinese national standards (GB standards), such as GB 4793.1 (safety requirements for electrical equipment for measurement, control, and laboratory use). For medical centrifuges, compliance with YY/T standards (e.g., YY 0648) is mandatory. Additionally, obtain CCC (China Compulsory Certification) if the product falls under the CCC catalog—though many laboratory centrifuges are exempt if classified under HS codes not requiring CCC. Provide technical documentation, including electrical safety, EMC (GB 4824), and risk assessment reports, in Chinese or with certified translations.

Import Procedures and Customs Documentation

Prepare a complete import package including commercial invoice, packing list, bill of lading, and contract. Include the product’s HS code, final use statement, and manufacturer details. For regulated centrifuges, submit the NMPA registration certificate or exemption proof. Appoint a licensed Chinese customs broker to assist with customs clearance. Be prepared for customs inspections, especially for high-value or medical equipment. Accurate classification is critical to avoid delays or penalties.

Labeling and Language Requirements

All labels, user manuals, and safety instructions must be in Simplified Chinese. Labels should include product name, model number, voltage, power rating, manufacturer information, and any required warning symbols. Medical devices must also display the NMPA registration number and the name of the registered agent in China. Non-compliant labeling can result in shipment rejection.

After-Sales Service and Maintenance Compliance

Establish a service network or partner with a local authorized service provider if the centrifuge requires maintenance or calibration. For medical devices, post-market surveillance and adverse event reporting are required under NMPA regulations. Maintain records of device performance and service history for audit purposes.

Environmental and Disposal Regulations

Follow China’s regulations on the disposal of electronic and laboratory waste (under the Solid Waste Law and Measures for the Administration of Import of Solid Wastes). Ensure that components such as motors, batteries, or refrigerants (if applicable) meet environmental standards. Avoid importing centrifuges containing ozone-depleting substances or restricted chemicals under China’s Montreal Protocol implementation.

Restricted or Dual-Use Considerations

Verify that the centrifuge does not fall under China’s dual-use or high-technology export/import control lists, particularly if it is designed for ultra-high-speed separation (e.g., uranium enrichment). Most laboratory and medical centrifuges are not subject to these controls, but confirmation with the Ministry of Commerce (MOFCOM) is advised for specialized models.

Declaration: Companies listed are verified based on web presence, factory images, and manufacturing DNA matching. Scores are algorithmically calculated.